Discounts

Early bird discount for Antibiotic resistance and antibiotic alternatives: Looking towards the future

Off

This international interdisciplinary event is an open forum for discussion of the rise in antibiotics resistance and the potential utility of various antibiotic alternatives in treating human and animal disease.  

Using a multi-professional and inter-specialty approach this event promises plenty of opportunity for discussion and debate set in an informal atmosphere.


Find out more about the Euroscicon Event

A late registration fee applies after Sept 20th 2015

This event has CPD accreditation

Who Should Attend
From researchers trying to find alternatives to therapies to pharmacists delivering treatments: any one with an interest in antibiotic alternatives would find this event of value.

This event has an open abstract session.

Abstracts can be submitted on any subject related to antibiotic resistance and alternatives
Abstracts for poster presentation only can be submitted up to two weeks before the event
You can download the instructions for authors at www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
Hashtag: #Antibio2015

 

Registration includes entry to all the event, lunch and all refreshments, networking opportunities and access to exhibitions.

FEE  FOR  THREE  DAYS

 

REGISTRATION FEE

LATE REGISTRATION FEE

Standard

 £445 + VAT

 £545 + VAT

Academic

 £295 + VAT

 £395 + VAT

Student

 £195 + VAT

 £295 + VAT

If you do not want to attend the full three days you can also book single days at the following price

 

REGISTRATION FEE

 LATE REGISTRATION FEE

Standard

£195 + VAT

 £275 + VAT

Academic

£125 + VAT

 £195 + VAT

Student

£95 + VAT

 £145 + VAT

 

RSS Free Biotechnology & Pharmaceuticals Magazines

  • Trends and Developments in Gene Therapy
    Five years from now, the Food and Drug Administration expects it will be clearing 10 to 20 cell and gene therapy products a year. Yet while the arrival of gene therapy's moment may be clear, its effects on a healthcare system designed around chronic treatment are not. INCLUDED IN THIS TRENDLINE Trends and challenges in the […]